If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,170.00    -25.00 (-0.35%)
Bid:
7,165.00
Ask:
7,175.00
Spread: 10.00 (0.14%)
Market Cap: £9.61b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Holding(s) in Company

7 Dec 2007 17:05

Diploma PLC07 December 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: DIPLOMA PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : Exemption Trading Book DTR 5.1.3 (4) ( X ) 3. Full name of person(s) subject to the notification obligation: The Goldman Sachs Group, Inc. 4. Full name of shareholder(s) (if different from 3.): Goldman, Sachs & Co.Goldman Sachs Asset Management International & Goldman Sachs Asset Management, L.P 5. Date of the transaction and date on which the threshold is crossed or reachedif different): 05 DECEMBER 2007 6. Date on which issuer notified: 07 DECEMBER 2007 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction Number of shares Number of voting Rights GB0001826634 928,631 4.10% Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Direct Indirect Direct Indirect GB0001826634 1,229,256 5.43% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 1,229,256 5.43% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: The interest in 1,147,799 shares arose from an interest held by Goldman, Sachs &Co., a wholly-owned direct subsidiary of GS Inc, acting as custodian for itscustomers. These shares are, or will be, registered in the name of Goldman SachsSecurities (Nominees), Limited. The interest in 1,459 shares arose from the interest held by Goldman Sachs AssetManagement International, a wholly owned subsidiary of GS Inc acting asdiscretionary manager. We believe that some of these shares are, or will be,registered in the name of Goldman Sachs Securities (Nominees), Limited ("GSSN"). The interest in 79,998 shares arose from the interest held by Goldman SachsAsset Management, LP a wholly owned subsidiary of GS Inc acting as discretionarymanager. We believe that some of these shares are, or will be, registered in thename of Goldman Sachs Securities (Nominees), Limited ("GSSN"). Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: General email contact: shareholderdisclosures:gs.com 14. Contact name: Sean Rogers / Alan Cox 15. Contact telephone number: 0207-552-9205 / 0207-774-8774 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.